Splash Beverage submits NYSE compliance plan; Medterra CBD deal expires

Splash Beverage submitted a compliance plan to NYSE American on May 28, 2026 to address stockholders' equity concerns, with potential cure period through January 29, 2027. The company's non-binding letter of intent with Medterra CBD expired on May 4, 2026, but management continues evaluating multiple strategic transaction opportunities in the cannabinoid wellness sector.